Literature DB >> 23385818

Regulation of DU145 prostate cancer cell growth by Scm-like with four mbt domains 2.

Kwanghyun Lee1, Wonho Na, Je-Heon Maeng, Hongjin Wu, Bong-Gun Ju.   

Abstract

Mammalian SFMBTs have been considered to be polycomb group repressors. However, molecular mechanisms underlying mammalian SFMBTs-mediated gene regulation and their biological function have not been characterized. In the present study, we identified YY1 and methylated histones as interacting proteins of human SFMBT2. We also found that human SFMBT2 binds preferentially to methylated histone H3 and H4 that are associated with transcriptional repression. Using DU145 prostate cancer cells as a model, we showed that SFMBT2 has a transcriptional repression activity on HOXB13 gene expression. In addition, occupancy of SFMBT2 coincided with enrichment of diand tri-methylated H3K9 and H4K20 as well as tri-methylated H3K27 at the HOXB13 gene promoter. When SFMBT2 was depleted by siRNA in DU145 prostate cancer cells, significant up-regulation of HOXB13 gene expression and decreased cell growth were observed. Collectively, our findings indicate that human SFMBT2 may regulate cell growth via epigenetic regulation of HOXB13 gene expression in DU145 prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23385818     DOI: 10.1007/s12038-012-9283-6

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  27 in total

Review 1.  Polycomb group protein-mediated repression of transcription.

Authors:  Lluís Morey; Kristian Helin
Journal:  Trends Biochem Sci       Date:  2010-03-24       Impact factor: 13.807

2.  A Polycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activities.

Authors:  Tetyana Klymenko; Bernadett Papp; Wolfgang Fischle; Thomas Köcher; Malgorzata Schelder; Cornelia Fritsch; Brigitte Wild; Matthias Wilm; Jürg Müller
Journal:  Genes Dev       Date:  2006-04-17       Impact factor: 11.361

3.  The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains.

Authors:  Sebastian Maurer-Stroh; Nicholas J Dickens; Luke Hughes-Davies; Tony Kouzarides; Frank Eisenhaber; Chris P Ponting
Journal:  Trends Biochem Sci       Date:  2003-02       Impact factor: 13.807

4.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.

Authors:  Celina G Kleer; Qi Cao; Sooryanarayana Varambally; Ronglai Shen; Ichiro Ota; Scott A Tomlins; Debashis Ghosh; Richard G A B Sewalt; Arie P Otte; Daniel F Hayes; Michael S Sabel; Donna Livant; Stephen J Weiss; Mark A Rubin; Arul M Chinnaiyan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

5.  The PcG gene Sfmbt2 is paternally expressed in extraembryonic tissues.

Authors:  Anastasia Kuzmin; Zhiming Han; Michael C Golding; Mellissa R W Mann; Keith E Latham; Susannah Varmuza
Journal:  Gene Expr Patterns       Date:  2007-10-09       Impact factor: 1.224

6.  Human SFMBT is a transcriptional repressor protein that selectively binds the N-terminal tail of histone H3.

Authors:  Shumin Wu; Raymond C Trievel; Judd C Rice
Journal:  FEBS Lett       Date:  2007-06-21       Impact factor: 4.124

7.  Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.

Authors:  Antonis Kirmizis; Stephanie M Bartley; Andrei Kuzmichev; Raphael Margueron; Danny Reinberg; Roland Green; Peggy J Farnham
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

8.  Gene therapy for head and neck squamous cell carcinoma using KITENIN (KAI1 COOH-Terminal Interacting Tetraspanin)-antisense therapy.

Authors:  Joon Kyoo Lee; Dong-Hoon Lee; Eun Gene Sun; Jeong A Bae; Sang Chul Lim; Jeong Joon Min; Myung-Whun Sung; Kyung Keun Kim
Journal:  Yonsei Med J       Date:  2011-05       Impact factor: 2.759

Review 9.  MBT domain proteins in development and disease.

Authors:  Roberto Bonasio; Emilio Lecona; Danny Reinberg
Journal:  Semin Cell Dev Biol       Date:  2009-09-22       Impact factor: 7.727

10.  Determination of enriched histone modifications in non-genic portions of the human genome.

Authors:  Jeffrey A Rosenfeld; Zhibin Wang; Dustin E Schones; Keji Zhao; Rob DeSalle; Michael Q Zhang
Journal:  BMC Genomics       Date:  2009-03-31       Impact factor: 3.969

View more
  8 in total

1.  Audiogenic seizure proneness after methyl-enriched diet in ontogeny.

Authors:  N M Surina; V V Ashapkin; I B Merzalov; O V Perepelkina; I B Fedotova; G V Pavlova; I I Poletaeva
Journal:  Dokl Biol Sci       Date:  2014-03-22

2.  TRPM2 promotes the proliferation and invasion of pancreatic ductal adenocarcinoma.

Authors:  Rui Lin; Yufeng Wang; Quanning Chen; Zhongyan Liu; Shuai Xiao; Bingyi Wang; Baomin Shi
Journal:  Mol Med Rep       Date:  2018-03-28       Impact factor: 2.952

3.  Down-regulated in OA cartilage, SFMBT2 contributes to NF-κB-mediated ECM degradation.

Authors:  Safdar Hussain; Mengyao Sun; Zixin Min; Yuanxu Guo; Jing Xu; Nosheen Mushtaq; Lisong Heng; Huang Huang; Yitong Zhao; Ying Yuan; Nazim Hussain; Fujun Zhang; Yan Han; Peng Xu; Jian Sun; Shemin Lu
Journal:  J Cell Mol Med       Date:  2018-08-22       Impact factor: 5.310

4.  circ‑0000212 promotes cell proliferation of colorectal cancer by sponging miR‑491 and modulating FOXP4 expression.

Authors:  Hongyu Wu; Yangbao Tao; Weiyuan Zhang; Guiyu Wang; Qian Zhang
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

5.  Pinpointing miRNA and genes enrichment over trait-relevant tissue network in Genome-Wide Association Studies.

Authors:  Binze Li; Julian Dong; Jiaqi Yu; Yuqi Fan; Lulu Shang; Xiang Zhou; Yongsheng Bai
Journal:  BMC Med Genomics       Date:  2020-12-28       Impact factor: 3.063

6.  Differential miRNA expression in inherently high- and low-active inbred mice.

Authors:  Michelle Dawes; Kelli J Kochan; Penny K Riggs; J Timothy Lightfoot
Journal:  Physiol Rep       Date:  2015-07-29

7.  SFMBT2 (Scm-like with four mbt domains 2) negatively regulates cell migration and invasion in prostate cancer cells.

Authors:  Jungsug Gwak; Jee Yoon Shin; Kwanghyun Lee; Soon Ki Hong; Sangtaek Oh; Sung-Ho Goh; Won Sun Kim; Bong Gun Ju
Journal:  Oncotarget       Date:  2016-07-26

Review 8.  The Two Sides of YY1 in Cancer: A Friend and a Foe.

Authors:  Sailu Sarvagalla; Srinivasa Prasad Kolapalli; Sivakumar Vallabhapurapu
Journal:  Front Oncol       Date:  2019-11-20       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.